Tests pulsed electromagnetic field therapy for muscle in prostate cancer patients
Tests pulsed electromagnetic fields on muscle in men with prostate cancer on hormone therapy.
Plain-language title generated from the registry record
Registry title: The Effect of Pulsed Electromagnetic Field Therapy on Muscle Mass and Muscle Strength in Prostate Cancer Patients Treated With Androgen Deprivation Therapy
Key facts
- Where
- Shatin, Hong KongSee the site
Where in Hong Kong
- Prince of Wales HospitalShatin, Hong KongTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Chinese University of Hong Kong
- Trial code
- NCT07057375
- Record updated
- 22 October 2026
- Original description
This study is to assess the effect of Pulsed electromagnetic fields (PEMF) on improving muscle mass and strength in prostate cancer patients with ADT.Read full original descriptionShow less
A Prospective Randomized Study to Investigate the Effect of Pulsed Electromagnetic Field Therapy on Muscle Mass and Muscle Strength in Prostate Cancer Patients Treated With Androgen Deprivation Therapy
This study is to assess the effect of Pulsed electromagnetic fields (PEMF) on improving muscle mass and strength in prostate cancer patients with ADT.
Inclusion: Adult patients with age greater than or equal to 18 years old; Histologically documented PCa; No evidence of distant metastasis (M1 disease); With ADT exposure from six months to three years; Expected to continue for at least six months; At least four weeks after radical prostatectomy or completed radiotherapy.
Exclusion: Patients are still under active treatment, such as radiotherapy; Patients who are unable to walk for 400 m or undertake exercise that will affect the clinical assessment of muscle strength; Patients with amputated lower limbs or other body deformities that will affect the treatment protocol.